Research Grade Gedivumab (DVV03804)

Catalog No.

DVV03804

Expression system

Mammalian Cells

Species reactivity

Influenza A virus

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

HA/Hemagglutinin

Concentration

1.4 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

C6KNH7

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

MHAA4549A, RO6876802, RG7745, CAS: 1807954-17-1

Clone ID

Gedivumab

Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection, PMID: 32621543

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, plus Oseltamivir in Patients Hospitalized with Severe Influenza A Virus Infection, PMID: 32393496

Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial, PMID: 28639229

Document Download

Research Grade Gedivumab.pdf